In the literature, increased levels of serum phosphorus and FGF23 levels have been linked to unexpected outcomes such as CKD (Musgrove and Wolf, 2019), hyperparathyroidism (Chou et al., 2019), and cardiovascular events (Schwantes-An et al., 2019) in humans. Here, FGF23 is linked to hyperparathyroidism.